Animal-to-human transplant of insulin-producing cells without use of drugs is ultimate goal
In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine scientists have successfully transplanted islets, the cells that produce insulin, from one species to another. And the islets survived without immunosuppressive drugs.
Northwestern scientists developed a new method that prevented rejection of the islets, a huge problem in transplants between species, called xenotransplantation. “This is the first time that an interspecies transplant of islet cells has been achieved for an indefinite period of time without the use of immunosuppressive drugs,” said study co-senior author Stephen Miller. “It’s a big step forward.” “Our ultimate goal is to be able to transplant pig islets into humans, but we have to take baby steps,” said Xunrong Luo, M.D., also co-senior author of the study that will be published online July 12 in the journal Diabetes. “Pig islets produce insulin that controls blood sugar in humans.”
Luo is an associate professor of nephrology at Northwestern University Feinberg School of Medicine and medical director of the Human Islet Cell Transplantation Program at Northwestern Memorial Hospital. Miller is the Judy Gugenheim Research Professor of Microbiology-Immunology at Feinberg. For people with hard-to-control type 1 diabetes, a transplant of insulin-producing islets from a deceased donor is one important way to control their chronic disease, in which their bodies do not produce insulin. However, there is a severe shortage of islet cells from deceased donors. Many patients on waiting lists don’t receive the transplant or suffer damage to their heart, nerves, eyes and kidneys while they wait.
Using islets from another species would provide wider access to transplants for humans and solve the problem. But concerns about controlling rejection of transplants from a different species have made that approach seem insurmountable until now. In the new study, scientists persuaded the immune systems of mice to recognize rat islets as their own and not reject them. Notably, the method did not require the long-term use of drugs to suppress the immune system, which have serious side effects. The islets lived and produced insulin in the mice for at least 300 days, which is as long as scientists followed the mice.
While the barrier from rats to mice is probably lower than from pigs to humans, the study showed interspecies islet transplants are possible and without immunosuppressive drugs, Luo said. In the study, the rat splenocytes, a type of white blood cell located in the spleen, were removed and treated with a chemical that caused their deaths. Next, the dead splenocytes were injected into the mice. The cells entered the spleen and liver and were mopped up by scavenger cells.
The scavengers processed the splenocytes and presented fragments of them on their cell surface, triggering a reaction that told the T cells to accept the subsequently transplanted rat islets and not attack them.
But rejection was still a threat. A unique challenge of an interspecies transplant is controlling the B cells, immune cells that are major producers of antibodies. Initially, when scientists transplanted the rat islets into the mice, the mouse immune system started producing antibodies against the rat cells causing rejection.
To solve the problem, Luo realized she needed to kill off the B-cells at the same time she injected the donor islets into the mice. Thus, she gave the mice B-cell depleting antibodies — already used in a clinical setting in human transplants. When the B-cells naturally returned after the transplant, they no longer attacked the rat islets. “With this method, 100 percent of the islets survived indefinitely,” Luo said. “Now we’re trying to figure out why the B-cells are different when they come back.”
The Latest Bing News on:
Interspecies Transplant
- Editor’s Rant: Fluency in fluon April 27, 2024 at 12:41 am
When this issue hits your mailbox (on or around May 7), we’ll be at about the peak of one of the best meteor showers Earth sees this year. Wishing on ...
- Hybrid Brains With Both Rat And Mouse Cells Created In Landmark Double Firston April 25, 2024 at 7:00 am
In a world first, two teams of scientists have independently created hybrid brain tissue with cells from two species: mice and rats. These two fuzzy rodents might look similar on the outside, but ...
- First pig kidney in a human: Is this the future of transplants?on April 12, 2024 at 2:00 am
Could the successful transplant of a gene-edited pig kidney to a human spell the end of the organ shortage crisis?
The Latest Google Headlines on:
Interspecies Transplant
[google_news title=”” keyword=”Interspecies Transplant” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diabetes Therapy
- Parents plead guilty in death of diabetic 4-year-old mostly fed soda through baby bottleon April 26, 2024 at 7:00 pm
Officials said 4-year-old Karmity Hoeb died at the hospital in January 2022. An autopsy revealed she died from a diabetes-related brain injury.
- Remove barriers to getting diabetes technologieson April 26, 2024 at 12:53 pm
Twenty-five years into the use and development of diabetes maintenance with CGMs, proven to decrease overall costs and increase standard of living, it is time for these barriers to be removed.
- Diabetes: Know Symptoms, Causes, Types And Treatmenton April 26, 2024 at 3:17 am
“Common symptoms of diabetes include feeling very thirsty, urinating a lot, being more tired than usual, losing weight without trying, and having blurry vision. If you notice these signs, see a doctor ...
- Diabetes drug shows promise for the treatment of acute heart failureon April 25, 2024 at 2:04 pm
A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a ...
- Inhaled insulin could improve lives of patients with diabeteson April 25, 2024 at 10:02 am
Millions of people around the world live with diabetes mellitus. Many of them have medication and specific dietary management approaches to help them maintain stable blood sugar levels. However, ...
- Treatment of osteoporosis with Denosumab associated with lower risk of incident diabetes especially among elderly: JAMAon April 25, 2024 at 8:45 am
Denosumab treatment is associated with a lower risk of incident diabetes especially among elderly patients with osteoporosis, suggests a new study published in the JAMA Network Open.Denosumab, ...
- Advanced insulin pumps enhance blood sugar management in type 1 diabeteson April 24, 2024 at 9:48 pm
Blood sugar levels improve when adults with type 1 diabetes use modern insulin pumps. These are the findings of a study conducted at the University of Gothenburg.
- Dr Beau Raymond: How Ochsner’s Digital Program Promotes Tailored Diabetes Managementon April 24, 2024 at 6:16 am
Diabetes treatment goals vary based on age and diabetes type, with more focus on managing insulin levels for children and adolescents while addressing comorbid conditions like obesity and hypertension ...
- Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidateson April 24, 2024 at 4:25 am
Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is Type 1 diabetes (T1D). | Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is ...
- American College Of Physicians Officially Recommends GLP-1s Like Ozempic For Diabetes Treatment—Despite Shortage Concernson April 19, 2024 at 10:10 am
The body for the first time is calling for GLP-1s as a treatment for Type 2 diabetes, but the medications are in short supply.
The Latest Google Headlines on:
Diabetes Therapy
[google_news title=”” keyword=”Diabetes Therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]